XM does not provide services to residents of the United States of America.

S&P 500 ends up, win streak at 5; Nasdaq ekes out gain even as Alphabet weighs



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-S&P 500 ends up, win streak at 5; Nasdaq ekes out gain even as Alphabet weighs</title></head><body>

S&P 500, Nasdaq extend win streaks to five

U.S. CPI rises as expected in July

Alphabet dips after report US mulls Google break-up

VIX records fastest ever drop from high-fear range

Indexes up: Dow 0.61%, S&P 500 0.38%, Nasdaq 0.03%

Adds closing prices

By David French

Aug 14 (Reuters) -The S&P 500 ended higheron Wednesday, stretching its winning streak to five sessions, as the latest inflation data reassured investors betting the Federal Reserve would start cutting U.S. interest rates next month.

The Nasdaq Composite also posted its fifth straight daily gain, although it barely scraped into positive territory asAlphabet and some megacap tech stocks weighed.

Moves were generally subdued with many investors away for August vacations, and new triggers for trading were absent, contributing to an overall listless picture among the benchmarks.

The latest U.S. consumer price data, released earlier on Wednesday, reinforced expectations that the Fed would start interest rate cuts inSeptember.

U.S. consumer prices rose moderately in July, and the annual increase in inflation slowed to below 3% for the first time since early 2021. A day earlier,softer-than-expected producer prices data indicated inflation continued to moderate, although not yet all the way to the U.S. central bank's 2% target.

Money markets now see a 55% chance of a 25-basis point (bps) rate cut at the Fed's Sept. 17-18 meeting, as per the CME FedWatch Tool. Before the data, traders were nearly evenly split between a 25-bps and 50-bps cut.

Scott Ladner, chief investment officer at Horizon Investments, said he called days such as this "markets violently going nowhere", adding with CPI painting a similar picture to PPI data, there was no reason for traders to reassess moves put in place on the previous day.

"There's no huge rationale to move prices one way or another," he said.

The S&P 500 .SPX closed at 5,455.21, up 0.38% or 20.78 points. The Nasdaq Composite .IXICclosed at 17,192.60, up 0.03% or 4.99 points. The Dow Jones Industrial Average .DJI closed up 242.75 points or 0.61% at 40,008.39.

Shares of Alphabet, the Google-parent GOOGL.O, dropped 2.3% on a media report that the U.S. Department of Justice is considering options that include breaking up the online search engine.

Other megacaps were mixed: Tesla TSLA.O slumped 3.1% andMeta Platforms dropped 0.3%, while Microsoft MSFT.O fell 0.7% andNvidia NVDA.O declined 1.7%.

A rebound in megacap and tech stocks has helped markets recoup most losses from a global market rout early this month after data showed the U.S. unemployment rate surged in July.

Thursday's release by the Commerce Department's Census Bureau of retail sales data will be keenly watched by those concerned about the overall strength of the American economy, Horizon's Ladner said.

These worries had sent the Cboe volatility index .VIX, Wall Street's fear gauge, to its highest since 2020 just last week. However, on Wednesday, it stayed below its long term average of 20 points for the second day to close at16.19.

The seven trading sessions it took the VIX to return to its long-term median of 17.6 is the index’s quickest ever drop from 35, a level associated with a high degree of fear, according to aReuters analysis.

A majority of the major S&P sectors were in positive territory, led by a 1.3% risein financials .SPSY. Its advance was aided by gains of more than 4.6% by Progressive PGR.N and Charles Schwab SCHW.N, which rose after positive July performance numbers, and Allstate ALL.N, which climbed after agreeing to sell a business unit.

Both of the insurers ended at record closing highs.

Kellanova K.N surged 7.8% afterfamily-owned candy giant Mars said it would buy the Cheez-It and Pringles maker in a nearly $36 billion deal.

Cardinal Health CAH.N gained 3.7% after the drug distributor raised its 2025 profit forecast.



Reporting by Medha Singh and Shashwat Chauhan in Bengaluru and David French in New York; Editing by Maju Samuel and David Gregorio

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.